Immunomodulators Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
Immunomodulator is a chemical agent employed to regulate or normalize the immune system of the human body. Immunomodulators can offer an effective treatment for inflammatory bowel disease (IBD), particularly its types: ulcerative colitis (UC) and Crohn’s disease (CD). Furthermore, they are widely used in organ transplantations and in the treatment of autoimmune diseases. Sometimes, steroids are prescribed to be used with immunomodulators to accelerate the effect of immunomodulators Market.
The global immunomodulators market is driven by the growing prevalence of autoimmune diseases, rising cases of organ transplantation, increasing prevalence of inflammatory bowel disease, high rates of diagnosis and treatment of the aforementioned disorders, growing awareness about IBD and autoimmune disorders, competition between key players and local players, and high availability of immunomodulators across the world. Remarkable investments in R&D and technological advancements are projected to propel the global immunomodulators market during the forecast period. On the other hand, the global immunomodulators market is likely to face challenges from side-effects (for example, pain, inflammation, hypertension, epilepsy, headache, etc.) of immunomodulators and stringent regulatory policies regarding immunomodulators.
Based on application, the global immunomodulators market can be segmented into human and veterinary. According to the Cancer Investigation, immunomodulators have exhibited strong efficacy in the treatment of cancer and AIDS. Furthermore, according to a study conducted by the International Journal of Oral Health & Medical Research, immunomodulators are effective options for the treatment of oral diseases. In terms of disease type, the global immunomodulators market can be segmented into inflammatory bowel disease (IBD), autoimmune diseases, organ transplantations, cancer, and others (AIDS, oral diseases, etc.). Based on drug type, immunomodulators market has been divided into immuno-suppressants and immuno-stimulants. In terms of route of administration, the global immunomodulators market can be segmented into oral, parenteral, and others. Based on distribution channel, immunomodulators market can be categorized into hospital pharmacies, retail pharmacies & drugs stores, and others.
Geographically, the global immunomodulators market has been classified into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to Centers for Disease Control & Prevention (CDC), around 0.24% and 0.29% of the people in the U.S. suffered from Crohn’s disease and ulcerative colitis respectively, in 2016. On the other hand, the estimated rate of prevalence of Crohn’s disease and ulcerative colitis stood at 0.0015%–0.21% and 0.0024%–0.294% respectively, in 2016, representing high prevalence of the two diseases in Nordic countries and the U.K. North America and Europe are expected to hold significant shares of the global immunomodulators markets during the forecast period, owing to significant prevalence of Crohn’s disease and ulcerative colitis, high incidence of autoimmune diseases, growing number of organ transplantation cases, technological advancements, wide availability of immunomodulator products, and developed health care infrastructure in these regions. Asia Pacific is estimated to hold the third-largest share of the global immunomodulators market between 2017 and 2025. Immunomodulators market in the region is anticipated to expand at the maximum growth rate during the forecast period, due to large patient pool, growing awareness about Crohn’s disease and ulcerative colitis, availability of generic immunomodulators, presence of local players, and competition between key players and local players in the region. Latin America and Middle East and Africa are anticipated to display sluggish growth during the forecast period. Indu
Key players operating in the global immunomodulators market are Biocon, AbbVie Inc., Bristol-Myers Squibb Company, Celgene Corporation, Antares Pharma, Inc., Zydus Pharmaceuticals, Inc., Teva Pharmaceuticals, Patterson Veterinary, GlaxoSmithKline plc, Salix Pharmaceuticals, Interferon Sciences, Inc., Amgen Inc., REGENERON PHARMACEUTICALS, Biogen, CSL Behring, Bayer AG, and Novartis Pharmaceuticals Corporation. Notable events in immunomodulators market include: a) recall of histocyamine sulphate by Virtus Pharmaceuticals Opco II, LLC in September 2016 and b) launch of innovative macrocyclic peptides by Bristol-Myers Squibb Company in August 2017.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017